共 50 条
- [1] TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcomaBRITISH JOURNAL OF CANCER, 2021, 125 (04) : 576 - 581Casey, Dana L.Pitter, Kenneth L.Wexler, Leonard H.Slotkin, Emily K.Gupta, Gaorav P.Wolden, Suzanne L.
- [2] p53 Pathway Mutations Increase Radioresistance in Rhabdomyosarcoma and Ewing SarcomaINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S179 - S179Casey, D. L.Pitter, K. L.Wexler, L.Slotkin, E.Gupta, G. P.Wolden, S. L.
- [3] Low prevalence of TP53 mutations in pediatric rhabdomyosarcomaCANCER RESEARCH, 2010, 70Ognjanovic, SimonaMartel-Planche, GhyslaineOlivier, MagaliHainaut, Pierre
- [4] Characterizing TP53 mutations in bone and soft tissue sarcomaJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Babatunde, OlayodeNotti, Ryan QuinTap, William D.
- [5] Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcomaSCIENTIFIC REPORTS, 2023, 13 (01):Kim, Jin-AhCrawford, Kenneth A.Spada, Piero A.Martin, Leah R.Zhang, JiaqiWong, RainReid, Joel M.Stewart, Clinton F.Frank, Timothy M.Liu, QianqianMichalek, Joel E.Keller, Charles
- [6] Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcomaScientific Reports, 13 (1)Jin-Ah KimKenneth A. CrawfordPiero A. SpadaLeah R. MartinJiaqi ZhangRain WongJoel M. ReidClinton F. StewartTimothy M. FrankQianqian LiuJoel E. MichalekCharles Keller
- [7] The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcomaJOURNAL OF VETERINARY MEDICAL SCIENCE, 2019, 81 (03): : 353 - 356Asada, HajimeIchii, OsamuTomiyasu, HirotakaUchida, KazuyukiChambers, James K.Goto-Koshino, YukoOhno, KoichiKon, YasuhiroTsujimoto, Hajime
- [8] Frequent Inactivating Mutations of the Cohesin Complex Gene STAG2 in Ewing's Sarcoma Associated with TP53 Mutations and Poor OutcomeLABORATORY INVESTIGATION, 2014, 94 : 29A - 29ASolomon, D. A.Brohl, A.Kim, J-SChang, W.Song, Y.Guerrero, J. A. LopezMachado, I.Wang, Z.Phillips, J. J.Wai, D. H.Shahbazian, V.Sorensen, P.Horvai, A. E.Triche, T. J.Miettinen, M.Llombart-Bosch, A.Waldman, T.Khan, J.
- [9] Frequent Inactivating Mutations of the Cohesin Complex Gene STAG2 in Ewing's Sarcoma Associated with TP53 Mutations and Poor OutcomeMODERN PATHOLOGY, 2014, 27 : 29A - 29ASolomon, D. A.Brohl, A.Kim, J-SChang, W.Song, Y.Lopez Guerrero, J. A.Machado, I.Wang, Z.Phillips, J. J.Wai, D. H.Shahbazian, V.Sorensen, P.Horvai, A. E.Triche, T. J.Miettinen, M.Llombart-Bosch, A.Waldman, T.Khan, J.
- [10] Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 MutationsCANCER DISCOVERY, 2014, 4 (11) : 1342 - 1353Tirode, FranckSurdez, DidierMa, XiaotuParker, MatthewLe Deley, Marie CecileBahrami, ArmitaZhang, ZhaojieLapouble, EveGrossetete-Lalami, SandrineRusch, MichaelReynaud, StephanieRio-Frio, ThomasHedlund, ErinWu, GangChen, XiangPierron, GaelleOberlin, OdileZaidi, SakinaLemmon, GordonGupta, PankajVadodaria, BhavinEaston, JohnGut, MartaDing, LiMardis, Elaine R.Wilson, Richard K.Shurtleff, SheilaLaurence, ValerieMichon, JeanMarec-Berard, PerrineGut, IvoDowning, JamesDyer, MichaelZhang, JinghuiDelattre, Olivier